Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Biochem Pharmacol. 2016 Sep 8;119:76–84. doi: 10.1016/j.bcp.2016.09.003

Figure 2.

Figure 2

Correlations between DABE, M1, M2 activations and CES1 and CES2 activities in 104 individual human liver samples. CES1 and CES2 activities were measured using the selective CES1 substrate oseltamivir and the selective CES2 substrate fluorescein diacetate, respectively. Data are the means from two independent experiments. (A) DABE vs oseltamivir; (B) M1 vs oseltamivir; (C) M2 vs oseltamivir; (D) DABE vs fluorescein diacetate; (E) M1 vs fluorescein diacetate; (F) M2 vs fluorescein diacetate.